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Summary 
A strong connection exists between the cell cycle and mechanisms required for executing 
cell fate decisions in a wide-range of developmental contexts. Terminal differentiation is 
often associated with cell cycle exit, while cell fate switches are frequently linked to cell 
cycle transitions in dividing cells. These phenomena have been investigated in the context 
of reprogramming, differentiation and trans-differentiation but the underpinning molecular 
mechanisms remain unclear. Most progress to address the connection between cell fate 
and the cell cycle has been made in pluripotent stem cells where the transition through 
mitosis and G1-phase is critical for establishing a window of opportunity for pluripotency 
exit and the initiation of differentiation. This Review will summarize recent developments 
in this area and place them in a broader context that has implications for a wide-range of 
developmental scenarios.  
 
Introduction 
The identity of a cell can be defined by its specific, metastable program of transcription 
and by the activity of cell-type specific transcription factors. Cell-type specific patterns of 
chromatin organization and epigenetic modifications are crucial for the establishment and 
maintenance of these transcriptional programs. In order to transition from one state to 
another, cells must modify their transcriptome, epigenetic landscape and chromosome 
architecture in a highly coordinated way. Over the last quarter of a century, numerous 
observations have established a role for the cell cycle in broad aspects of cell fate 
decisions, and have shown that the expression of cell fate 'decision' genes is often 
coupled to cell cycle regulatory mechanisms (Fig. 1). These studies show that the cell 
cycle machinery impacts chromosome architecture, the epigenome and transcriptional 
programs required for cell identity in multiple contexts including differentiation, 
reprogramming and trans-differentiation.  
 Reprogramming differentiated cells was first demonstrated by exposing the 
nucleus of a somatic cell to the cytoplasm of an enucleated egg using somatic cell nuclear 
transfer (SCNT), generating animals ranging from frogs to primates (Briggs and King, 
1952; Campbell et al., 1996; Gurdon, 1962; Tachibana et al., 2013; Wakayama et al., 
1998). Similarly, it is possible to trans-differentiate cells from one differentiated type to 
another by exposing the nucleus of a donor cell to the cytoplasm of another cell. An 
example of this is the fusion between human fibroblasts and mouse muscle cells, which 
results in the induction of muscle-specific genes in the human genome (Blau et al., 1983). 
Pre-existing trans-acting factors in the recipient cytoplasm can therefore reset the 
transcriptional program of a donor somatic genome. Shortly after this discovery, ectopic 
expression of MYOD was shown to be sufficient for the conversion of fibroblasts to 
myoblasts, demonstrating that specific transcription factors can redirect cell identity 
(Davis et al., 1987). More recently, Takahashi and Yamanaka showed that OCT4, SOX2, 
KLF4, and MYC (together abbreviated as OSKM), are sufficient to convert somatic cells 
to the pluripotent state, thereby generating induced pluripotent stem cells (iPSCs) 
(Takahashi and Yamanaka, 2006). Together, these studies reveal that cell-type specific 
transcription factors are central to the cell fate decision making process (Graf and Enver, 
2009; Xu et al., 2015). Numerous observations have identified important connections 
between these transcriptional master regulators, cell-state transitions and the cell cycle, 
although the molecular mechanisms that connect these processes are only starting to be 
elucidated. This Review will begin by broadly summarizing the role of the cell cycle in 
differentiation, reprogramming and trans-differentiation in developmental models ranging 
from yeast to humans. Then, attention will specifically focus on the role of cell cycle 
regulatory mechanisms in cell fate decisions made by pluripotent stem cells (PSCs).  
Finally, we put forth our views on how placing cell fate decisions within the context of cell 
cycle will have implications for a broad spectrum of developmental decisions and will likely 
change our current methods in manipulating cell identity for clinical purposes and for 
understanding human disease. 
 
Progression through the cell cycle as a cell fate decision 
Progression through the cell cycle involves a sequence of events in which chromosomes 
are replicated during S-phase and then segregated to daughter cells during M-phase 
(Morgan, 1995). These key events are separated by gap phases that serve as regulatory 
windows to ensure that cell cycle events occur at the correct time and in the right order. 
All of these events are orchestrated by the activity of cyclin-dependent kinases (CDKs) 
that phosphorylate substrates required for the different cell cycle transitions. The gap 
phase separating M-phase from S-phase is known as G1-phase and marks the time when 
cells make the decision to exit the cell cycle or continue through further rounds of division. 
This decision is classically thought of as being controlled through the phosphorylation of 
retinoblastoma (RB) family proteins by CDKs, thereby establishing a binary switch 
mechanism known as the Restriction (R-) point that gates cell cycle progression in G1-
phase (Blagosklonny and Pardee, 2002). Recent evidence suggests that the CDK-
dependent G1 decision point in cycling cells may actually initiate upon mitotic exit and 
may precede the classically defined R-point (Cappell et al., 2016; Spencer et al., 2013). 
The R-point mechanism links the cell cycle machinery to mitogenic signals and under the 
appropriate signaling conditions, genes required for G1-S progression are activated. This 
mechanism has enormous implications for control of normal cell growth and de-regulated 
proliferation in cancer. In a stem cell context, R-point control is critical in determining the 
balance between self-renewal, quiescence and differentiation of stem cell populations (Li 
and Clevers, 2010; Tetteh et al., 2015). For example, proliferative control of hematopoietic 
stem cells is a critical determinant that distinguishes normal and cancer-related 
hematopoietic function (Pietras et al., 2011). The developmental state of pluripotent cells 
can also be regulated by exit from the cell cycle. For example, PSCs exit the cell cycle 
and enter a 'dormant' developmental state that mimics diapause following MYC depletion 
(Scognamiglio et al., 2016). This is likely to be related to MYCs ability to control CDK 
activity and is an interesting example of how proliferation and developmental status are 
coupled. 
 Another broad example where cell cycle decisions are coupled to cellular decisions 
is exemplified by size control mechanisms in a wide-range of organisms (Ginzberg et al., 
2015). In principle, cells are required to achieve a critical volume in G1-phase before 
entering S-phase and committing to another round of cell division. If a cell is too small to 
sustain itself, it will delay progression into S-phase in an attempt to acquire sufficient 
volume by growth before it commits to another round of DNA replication and cell division. 
If size homeostasis is deregulated, a cell could potentially overgrow or reduce in size to 
the point where its function would be severely compromised. This process has been 
studied extensively in the budding yeast where size-regulated commitment to the cell 
cycle occurs at a point in G1-phase known as 'Start' (Jorgensen and Tyers, 2004). This 
control point is generally considered to be the equivalent of the mammalian R-point and 
involves a regulatory mechanism where nutrient and biosynthesis-regulated signaling 
pathways converge with the cell cycle machinery to coordinate cell volume with 
progression into S-phase (Ferrezuelo et al., 2012). The cell cycle machinery is also linked 
to cellular decisions that occur following environmental stress where cells undergo a 
checkpoint arrest or, alternatively undergo apoptosis (Carvajal and Manfredi, 2013). 
These fundamental examples of coordination between cellular decisions and the cell 
cycle have broad relevance to the function of multipotent cells in development. 
 
Cell identity and its coordination with the cell cycle  
Early work in yeast provided a mechanistic link between cell cycle machinery and 
changes in cell identity through double-strand break-induced recombination (Haber, 
1998). In this study, haploid budding yeast were found to switch between two different 
alleles of the mating-type (MAT) locus; a and , leading to mixtures of a and  cells that 
can mate and form a/ diploids. In each cell cycle, haploid cells could potentially undergo 
a mating type switch driven by expression of the HO endonuclease that acts on the MAT 
locus in G1-phase. In Dictyostelium development, amoeba decide to become pre-spore 
cells if they sense starvation conditions in G1-phase but, choose a pre-stalk fate under 
the same conditions in S- and G2-phases (Gomer and Firtel, 1987). This example is 
interesting because it indicates that commitment to different cell fates is determined at 
different stages of the cell cycle in multipotent cells. A similar conclusion has emerged 
from studies of C. elegans vulval development (Ambros, 1999). Here, the point at which 
lin-12 acts in the cell cycle impacts cell fate choice. Overall, these reports show that linking 
the cell cycle to cell fate decisions is a common theme in multipotent cells and is not 
restricted by species boundaries (Fig. 1). This principle also broadly applies to 
mammalian embryogenesis. During pancreatic development for example, endocrine 
progenitor cells adopt different fates depending on whether they are exposed to 
differentiation signals in early or late G1-phase (Kim et al., 2015). If exposure to signals 
occurs in early G1-phase, cells differentiate and exit the cell cycle through an asymmetric 
cell division. In contrast, if pancreatic progenitors are programmed in late G1-phase they 
complete the cell cycle and generate two differentiated endocrine cells. The time at which 
pancreatic progenitors receive induction signals in G1-phase is therefore critical in 
determining how they respond. This concept is reiterated in studies of murine neocortical 
development (McConnell and Kaznowski, 1991). Here, multipotent cortical progenitors 
respond to local induction cues generating different cell fate outcomes depending on 
where they are in the cell cycle at the time of induction. In murine fetal erythropoiesis, 
entry and progression through S-phase is required for activation of the erythroid 
differentiation program through the erythroid master regulator, GATA1 (Pop et al., 2010). 
Down-regulation of the cyclin-dependent kinase inhibitor (CDKI) KIP2p57 and the GATA1 
antagonist PU1 are key requirements of this cell cycle-dependent regulatory mechanism. 
Linking S-phase progression to cell fate decisions in multipotent cells has also been 
reported in the Drosophila central nervous system (Weigmann and Lehner, 1995).  
 So far, examples of cell fate decisions being initiated during G1- and S-phase have 
been described, but G2-phase is also potentially important for cellular decisions. During 
bristle patterning in Drosophila, Notch signaling controls transition through late stages of 
the cell cycle such that cells with elevated Notch signaling divide first and those with lower 
signaling extend their G2-phase and delay division (Hunter et al., 2016). This G2-phase 
transition time is critical in determining the decision of sensory organ precursor cells to 
undergo a microchaete fate or a neural fate. The timing of mitotic entry and duration of 
G2-phase in which cells are exposed to differentiation cues therefore impacts Notch-
mediated lateral inhibition and consequently, cell fate decisions. Studies in zebrafish 
(Bouldin and Kimelman, 2014), sea squirts (Ogura et al., 2011), frogs and flies (Davidson 
et al., 2009) reinforce this concept. Together, these studies show that although there are 
variations to the central theme, the mechanistic coupling of the cell cycle to cell fate 
decisions is a strong recurring biological theme in multipotent cells from diverse origins.  
 
Terminal differentiation and cell cycle exit 
Exit from the cell cycle in G1-phase is frequently required for terminal differentiation of 
cells during development. The mechanisms underlying this have been reviewed 
elsewhere (Buttitta and Edgar, 2007; Ruijtenberg and van den Heuvel, 2016) and so only 
the coordination between developmental programs and terminal differentiation will be 
highlighted here. In most cases, terminal differentiation is linked to the up-regulation of 
CDK inhibitor proteins (CDKIs), ensuring inhibition of CDK during G1 as well as hypo-
phosphorylation of the RB tumor suppressor protein family, which serves to repress the 
E2F target genes required for further cell cycle activity. It has been difficult to 
unequivocally establish the precise mechanism linking terminal differentiation to cell cycle 
exit but the two processes seem to be linked at several levels and are often mutually 
antagonistic. During skeletal myogenesis, CDKs inhibit the activity of myogenic 
transcription factors such as MYOD, thereby maintaining cells in a proliferative, immature 
state (Guo and Walsh, 1997; Rao et al., 1994; Skapek et al., 1995). A similar scenario 
has been described during neurogenesis where CDKs inhibit pro-differentiation 
transcription factors such as NGN2 (Hardwick and Philpott, 2014). It is also true, however, 
that MYOD counteracts the impact of CDKs by activating the expression of genes for 
CDK inhibitors such as CIP1p21 and KIP2p57 (Busanello et al., 2012; Halevy et al., 1995; 
Parker et al., 1995). Inhibition of CDKs then leads to cell cycle arrest in conjunction with 
the activation of terminal myogenic events. This theme is also seen during terminal 
differentiation of Drosophila neuroblasts (Choksi et al., 2006; Li and Vaessin, 2000). Here, 
the homeo-domain transcription factor Prospero (Pro) activates genes required for 
differentiation but also inhibits transcription of key cell cycle regulatory genes such as 
cyclin E and string and promotes transcription of the CDKI gene, dacapo (Choksi et al., 
2006; Li and Vaessin, 2000). These and other studies (Ruijtenberg and van den Heuvel, 
2016) indicate an inverse mechanistic relationship between the cell cycle and terminal 
differentiation in a broad spectrum of cell types. These events depend on the activity of 
G1-specific CDKs and their regulation of transcription factors required for developmental 
decisions. Conversely, transcription factors required for cell fate decisions serve to 
modulate CDK activity and drive exit from the proliferative state. The balance between 
CDK activity and transcription factor activity therefore serves as a cell fate decision 
'tipping point'. 
 Reprogramming, trans-differentiation and tissue regeneration 
The examples considered so far cover the relationship between cell cycle stage and 
cellular decisions during the process of differentiation. It is important however, to 
emphasize the requirement for cell cycle controls in other decision-making contexts such 
as reprogramming, trans-differentiation and regeneration, and to establish the similarities 
and differences among these contexts. Interestingly, several reports indicate that cell 
proliferation per se is not a critical determinant for changes in cell identity. In addition to 
terminal differentiation (Falcone et al., 1984), trans-differentiation of fibroblasts to 
myoblasts (Chiu and Blau, 1984) and reprogramming by SCNT (Halley-Stott et al., 2010; 
Jullien et al., 2010; Jullien et al., 2011) have no requirement for active cell division. This 
observation may also apply to some examples of transcription factor-induced cell fate 
changes. This includes the switch in exocrine to endocrine pancreatic identity following 
ectopic expression of NGN3, PDX1 MAFA in mice (Zhou et al., 2008) and the generation 
of neurons from fibroblasts following ectopic expression of ASCL1, BRN2 and MYT1L 
(Vierbuchen et al., 2010). Interestingly, ASCL1 was found to drive somatic cells to exit 
the cell cycle in trans-differentiation (Treutlein et al., 2016), while ASCL1 seems to drive 
quiescent adult hippocampal stem cells to re-enter the cell cycle during differentiation 
(Urbán et al., 2016). This suggests that the mechanistic coupling between transcription 
factors and the cell-cycle machinery is context dependent and may be determined by the 
specific level of the protein as well as the pre-existing molecular landscape specific to the 
starting cell (masserdotti et al., 2016). C/EBP-induced conversion of pre-B cells to 
macrophage-like cells however, can occur under proliferative and non-proliferative 
conditions (Di Tullio and Graf, 2012), but whether this involves two separate mechanisms 
is unclear. A caveat to some studies is that limited molecular characterization of trans-
differentiated cells has been performed, making it unclear whether a complete cell fate 
switch was accomplished in the absence of cell division (Cahan et al., 2014; Morris et al., 
2014). A growing amount of evidence however, does show a key role for active cell 
division in cell fate switching. During regeneration in Medusae, trans-differentiation of 
mono-nucleated muscle cells to other cell types including sensory cells requires active 
cell division (Schmid et al., 1988). Cardiac regeneration in zebrafish is also intimately 
linked to cell cycle regulators such as polo-like kinase 1 (plk1) in proliferating 
cardiomyocytes (Jopling et al., 2010; Poss et al., 2002). It is also clear that reduced 
proliferative capacity represents a major barrier for reprogramming to the pluripotent state 
(Hong et al., 2009; Kawamura et al., 2009; Ruiz et al., 2011; Utikal et al., 2009) and there 
are several cases where active cell division is an important requirement for directed trans-
differentiation (Feng, 2016; Jiang et al., 2015) in response to reprogramming factors.  
 Although continued cell division is a requirement for cell fate changes in many 
instances, it is unclear why it may not be necessary in all situations. Subtle differences in 
the barriers that cells face as they undergo identity changes could explain variations in 
cell cycle-dependency. For example, reprogramming of fibroblasts to the pluripotent state 
is generally associated with extensive erasure and reestablishment of a DNA methylation 
signature (Lister et al., 2009; Lister et al., 2011) but in B-cells, no major changes in DNA 
methylation are required (Di Tullio and Graf, 2012). If the erasure of DNA methylation or 
other epigenetic signatures requires active cell division, this could explain some of the 
discrepancies described above. It is also possible that DNA replication rather than cell 
division is mechanistically important for reprogramming (Lavagnolli et al., 2015). Also, the 
dependency of a lineage-specifying transcription factor on CDK for activation could 
explain differences in various stem/progenitor cells.  
 
Cell fate decisions are linked to G1-phase progression in PSCs 
In the early mammalian embryo, cells transition through pluripotency during the pre-, peri, 
and post-implantation phases. Pluripotent cells that exist during peri-implantation 
development have short generation times but the cell cycle lengthens significantly as cells 
differentiate along the germ layer lineages (Lawson and Pedersen, 1992; Mac Auley et 
al., 1993; Snow and Bennett, 1978). Similar trends have been described for PSCs 
cultured in vitro (Boward et al., 2016). Rapid cell division is associated with a truncated 
G1-phase and only a short delay before cells enter S-phase after exiting M-phase. The 
absence of fully-formed gap phases establishes a situation wherein PSCs spend 50-65% 
of their time in S-phase. As PSCs commit to one of the three embryonic germ layers their 
progeny acquire an extended G1-phase, resulting in increased cell division times. This 
can be accounted for by a fundamental change in the regulation of CDK activity (Faast et 
al., 2004; Stead et al., 2002; White et al., 2005). It has been assumed, mainly for 
anecdotal reasons, that the low G1-phase/high S-phase cell cycle structure of PSCs 
supports pluripotency by limiting the time cells are exposed to specification signals. As 
differentiation initiates, an elongated G1-phase would then make cells more susceptible 
to irreversible germ-layer commitment. Several reports have now established this concept 
experimentally. For example, if the length of G1-phase is increased through inhibition of 
CDK activity, PSCs spontaneously differentiate (Neganova et al., 2008; Ruiz et al., 2011). 
More recently, the strategic advantage of having a cell cycle with a short G1-phase has 
been demonstrated at the molecular level (Boward et al., 2016).  
 Although multiple laboratories showed that PSCs respond to induction signals in 
G1-phase over two decades ago (Mummery et al., 1987; Pierce et al., 1984; Wells, 1982) 
this general observation was not fully explored until recently, when the fluorescence 
ubiquitin cell cycle indicator (Fucci) reporter system was used to explore this phenomenon 
(Sakaue-Sawano et al., 2008). In a seminal report, Pauklin and Vallier (Pauklin and Vallier, 
2013) confirmed that PSCs initiate cell fate decisions when in G1-phase, but they also 
identified an unanticipated mechanism where mesoderm and endoderm commitment 
occurs in early G1-phase and ectoderm commitment is restricted to late G1-phase (Fig. 
2). This partitioning of G1-phase along germ layer boundaries is related the elevated 
activity of SMAD2,3 in early G1 and its inactivation in late G1. The former is dependent 
on ACTIVIN A signaling and the latter dependent on the removal of SMAD2,3 from target 
genes by Cyclin D activity. Because mesoderm and endoderm differentiation requires 
SMAD2,3 activity and because ectoderm requires pan-SMAD inhibition, this mechanism 
provides an insightful explanation for how cell fate commitment is partitioned into different 
stages of G1-phase. It also provides a mechanistic link between the cell cycle regulated 
activity of G1-phase cyclins and developmental genes required for cell fate decisions.  
 An additional report using the Fucci system to dissect cell cycle events has since 
been published, focusing on the links between epigenetic events and the cell cycle (Singh 
et al., 2016). In this study, Singh and co-workers characterized the epigenetic changes 
that occur in self-renewing hPSCs and found that H3K4 trimethylation within bivalent 
domains of developmental genes increases in G1-phase while H3K27me3 repressive 
marks remain constant (Fig. 2). This establishes that bivalent domains of H3K4me3 and 
H3K27me3 are enriched in G1-phase and that throughout the remaining part of the cell 
cycle developmental genes are marked primarily by H3K27me3. This is an intriguing 
observation because it establishes a level of dynamic epigenetic regulation at 
developmental genes that was not previously appreciated. Consistent with changes in 
H3K4me3 in G1-phase, developmental genes become transcriptionally competent (Singh 
et al., 2013). The study suggests that developmental genes are primed for activation each 
time they go through G1-phase but are not activated unless the appropriate signaling 
networks are also active. In support of this, chromatin conformation-capture assays (4C) 
showed that G1-specific epigenetic changes at developmental genes coincide with the 
establishment of DNA loops that bridge distal enhancers with proximal promoters (Fig. 
2). Chromosome architectural changes in G1-phase require increased H3K4me3 at the 
bivalent domain along with increased CDK2 activity, indicating a functional link between 
epigenetic remodeling, chromosome architectural changes and the cell cycle machinery. 
Although the mechanism by which CDKs control chromosome architecture at bivalent 
genes hasn't yet been established these studies indicate that in each G1-phase, the 
epigenetic landscape and chromosome architecture changes so that it puts 
developmental genes in a 'lineage-primed' state. The potential mechanisms by which 
CDKs remodel chromatin and activate developmental genes in G1-phase could be direct 
or indirect, but potentially could involve the direct phosphorylation of chromatin 
remodeling enzymes or sequence-specific transcription factors. In summary, a 
combination of epigenetics, chromosome architecture and transcription factor recruitment 
appear to be involved in priming developmental genes for G1-specific differentiation. CDK 
activity has been implicated in control of these regulatory steps (Pauklin and Vallier, 2013; 
Singh et al., 2015) (Fig. 2), establishing a link between cell fate decisions and the cell 
cycle machinery.  
 
Entry to and exit from G1 phase  
The idea that the transition from mitosis to G1-phase might establish conditions in which 
switching of lineage-specific transcriptional programs is possible is supported by studies 
showing that this window of the cell cycle represents a hyperactive, dynamic 
transcriptional state (Hsiung et al., 2016). This is consistent with earlier reports showing 
that developmental genes are primed for transcription in G1-phase (Singh et al., 2013; 
Singh et al., 2015). Increased transcription as cells transition into G1-phase is thought to 
localize at genomic regions pre-marked with H3K27ac. This hyper-transcriptional activity 
is not uniform and may also account for cellular heterogeneity (Hsiung et al., 2016). A 
recent study has revealed another interesting connection between exit from pluripotency 
and early cell fate decisions, this time involving S-phases and G2-phase. In this study, a 
high-throughput RNAi screen performed in hESCs identified cell-cycle genes involved in 
DNA replication and G2-phase progression that restrict exit from pluripotency or, 
'pluripotent state dissolution' (Gonzales et al., 2015). This is another line of evidence that 
supports the idea that the cell cycle state of PSCs is related to maintenance of the 
pluripotency. By devoting most time to S-phase and minimizing the time spent in G1-
phase, cells have little opportunity for dissolution of the pluripotent state. As G1-phase 
lengthens during differentiation, this would presumably cause an irreversible breakdown 
of the pluripotency network and enhance germ layer commitment. This is further evidence 
indicating that G1-phase represents a gateway for the initiation of cell fate decisions. 
 By integrating what we know so far, it is possible to envisage a model where the 
initiation of differentiation consists of at least two phases. The first phase would be 
pluripotent state dissolution in which the pluripotency network is inactivated, and second 
phase would be lineage commitment, where new transcriptional programs corresponding 
to germ layer formation are established. This latter step could involve a combination of 
bookmarking events during mitosis (see below and Box 1) and lineage priming in G1-
phase. Pluripotent state dissolution is then attenuated in S-phase and G2-phase by 
activities in these respective cell cycle phases, maintaining high levels of pluripotency 
factors such as NANOG and OCT4. This increase of NANOG and OCT4 is tightly 
controlled and more homogenous at the transcriptional level after DNA replication 
(Skinner et al., 2016). These findings support the model that G1-phase represents a 
window of time when cells are predisposed to initiate fate decisions. Thus, entry and exit 
from G1-phase is mechanistically linked to cell fate decisions in PSCs. 
 
Cyclin D connects the cell cycle to activation of developmental genes 
Paulkin and Vallier previously found that the CDK4,6-Cyclin D complexes impact 
ACTIVIN/NODAL signaling and promote human embryonic stem cell differentiation 
through phosphorylation of SMAD2,3 (Pauklin and Vallier, 2013). More recently however, 
the same laboratory reported that Cyclin D can influence cell fate decisions independently 
of SMAD2,3 inhibition and independently of its association with CDK4,6 (Pauklin et al., 
2016). This second mechanism of action requires the ability of Cyclin D to recruit 
transcriptional co-activators and co-repressors to developmental target genes as it 
accumulates during G1-phase (Fig. 2). For example, when Cyclin D1 is absent in early 
G1, the co-activator p300 is recruited to endoderm genes. However, when Cyclin D1 
accumulates in late G1, it recruits histone deacetylases (HDAC) in place of p300, which 
functions as a histone acetyltransferase (HAT) resulting in loss of the active histone 
acetylation and an increase in the repressive histone methylation H3K27me3 at these 
genes. Consistent with the G1-phase partitioning model, neuroectoderm genes are 
activated in late G1 by Cyclin D-dependent recruitment of p300 and increased H3K4me3 
at these genes. Recruitment of Cyclin D to ectoderm genes is dependent on SP1 whereas 
Cyclin D recruitment to endoderm genes is E2F-dependent. This work reinforces a 
number of principles that help us to understand how pluripotent stem cells initiate cell fate 
decisions from G1-phase. Importantly, Cyclin Ds can interact with transcription factors 
bound to developmental genes in G1-phase and have vastly differing effects on their 
regulation via their ability to recruit co-repressors or co-activators. The principle that CDK 
activities coordinate cell fate decisions at developmental genes in G1-phase is 
underscored by these observations. 
 
Mitosis and epigenetic memory  
DNA replication and mitosis represent two events that could facilitate global restructuring 
of chromatin during the cell cycle. During S-phase, re-establishing the chromatin state on 
newly synthesized DNA is potentially important for maintaining or switching cell identity. 
It is therefore conceivable that this represents a time when new, cell-type specific 
epigenetic landscapes can be founded. The inheritance of this epigenetic state through 
the S-phase can use the mother chromatin state as a template or be directly coupled to 
the DNA replication machinery (for recent reviews see (Ma et al., 2015; Probst et al., 
2009)). It is mitosis however, that has recently attracted most attention in this area, in part 
because of studies where asymmetric cell divisions have been implicated in cell fate 
changes (Arsenio et al., 2015; Congdon and Reya, 2008; Tran et al., 2012). The hallmarks 
of mitosis include chromosome condensation and nuclear envelope breakdown - both of 
which are under control of CDK activity. During M-phase, most transcription-associated 
factors including RNA polymerases dissociate from chromatin and the cell-type specific 
transcription programs temporarily halts (Egli et al., 2008; Gottesfeld and Forbes, 1997; 
Spencer et al., 2000). Furthermore, histone modifications such as global histone 
acetylation, which are associated with active gene expression, are generally diminished 
during mitosis (Kruhlak et al., 2001; McManus and Hendzel, 2006). Loss of histone tail 
acetylation such as H4K16 has been found to be directly linked to the mitotic-specific 
histone phosphorylation (H3S10P), promoting chromatin fiber condensation (Wilkins et 
al., 2014). However residual amounts of histone acetylation, which bookmarks a select 
group of gene promoters, has also been reported (Dey et al., 2009; Kouskouti and 
Talianidis, 2005; Valls et al., 2005; Zhao et al., 2011). Despite many repressive marks 
such as H3K9me3 and H3K27me3 being retained in mitotic chromatin (Follmer et al., 
2012; Li et al., 2006; McManus et al., 2006; Peters et al., 2002; Singh et al., 2015), the 
functional proteins - known as 'writers' and 'readers' - that deposit and associate with 
these marks, such as SUV39H1, HP1 and BMI1, are generally excluded from mitotic 
chromatin (Egli et al., 2008; Kellum et al., 1995; Minc et al., 1999; Voncken et al., 1999). 
Histone modifications during mitosis have been reviewed in more detail elsewhere (Wang 
and Higgins, 2013). In addition, the precise nucleosome positioning and histone variant 
distribution that usually mark cell-type specific promoters and enhancers are also lost 
during mitosis (Deniz et al., 2016; Kelly et al., 2010; Komura and Ono, 2005). This 
culminates in the erasure of cell type-specific, three-dimensional genomic organization 
(Dileep et al., 2015; Naumova et al., 2013) and the loss of genome-nuclear lamina 
interactions (Kind et al., 2013). Epigenetic erasure and chromosome remodeling could 
therefore explain the requirement for transition through mitosis in order to enhance 
cellular reprogramming, as discussed in more detail below.  
 Despite the global reorganization of the epigenome during mitosis, mitotic memory 
of active gene expression programs is retained. In effect, this may allow newly divided 
cells to pick up where they left off, either by preventing mitotic compaction of previously 
active DNA loci, or by facilitating reassembly of transcription complexes on the promoter, 
or both. This phenomenon is referred to as mitotic bookmarking (see Box 1), and has 
been shown to be important for the rapid reactivation of certain genes upon entry into G1-
phase. Thus, it is possible that the selective retention of certain marks over others may 
represent a means to instructing cell fate change in the newly divided cell. 
 
Mitosis as a window of opportunity for changes in cell fate  
It is well-established that chromosome condensation and nuclear envelope breakdown 
during mitosis are important for successful SCNT reprogramming of mammalian cells 
(Campbell et al., 1996). This general model is also supported by studies of SCNT in 
amphibians where somatic cells are most responsive to reprogramming factors present 
in the cytoplasm of unfertilized, metaphase II (MII)-arrested oocytes (Halley-Stott et al., 
2014). Histone H2A de-ubiquitination on mitotic chromatin but not interphase chromatin 
seems to contribute to this reprogramming responsiveness. Surprisingly, no other histone 
modification or epigenetic mechanism has been identified that, together with H2A de-
ubiquitination, enhances SCNT reprogramming in M-phase. It has been postulated that 
histone de-ubiquitination and chromatin condensation may enhance SCNT 
reprogramming not through the eviction or exclusion of factors from mitotic chromatin but 
instead, by facilitating factor exchange (Halley-Stott et al., 2014). Hyper-dynamic protein 
exchange is a feature of pluripotency which decreases following exit from the pluripotent 
state (Meshorer et al., 2006). This is also consistent with the dynamic binding of pioneer 
factors to mitotic chromatin (Caravaca et al., 2013). This pattern of dynamic protein 
exchange on chromatin may therefore be critical for establishing of the pluripotent state, 
but it could also establish conditions that predispose PSCs to differentiation or 
reprogramming following mitotic exit under the appropriate signaling conditions.   
 Mitosis may serve to provide a window of opportunity for reprogramming because 
reprogramming factors have preferential access to condensed chromatin and therefore 
face less competition from other factors that are excluded from target loci. It has been 
shown that OSK can access closed chromatin by acting as pioneer factors during iPSC 
reprogramming (Soufi et al., 2012; Soufi et al., 2015). However, whether these pioneer 
factors interact with mitotic chromatin is yet to be examined. Nevertheless, one can 
hypothesize that reprogramming factors have a unique ability to bookmark mitotic 
chromatin, enabling gene priming immediately following exit from mitosis and prior to 
gene reactivation (Fig. 3). Another mitotic advantage may be due to the exclusion of HP1 
and SUV39H1 from heterochromatin, which blocks access of the reprogramming factors 
to key pluripotency genes during interphase (Soufi et al., 2012) (Fig. 3). The association 
and dynamic exchange of reprogramming factors with mitotic chromatin functions to 
bookmark the genome, both specifically and non-specifically (Fig. 3). This landscape is 
then reset upon mitotic exit and potentially establishes a new epigenomic state for cell 
fate conversion.  
 The mitotic advantage in reprogramming is not restricted to unfertilized oocytes 
but is applicable to other advanced embryonic stages as well. For example, mouse 
zygotes and electro-fused blastomeres arrested in mitosis can acquire a reprogramming 
capacity in SCNT (Egli et al., 2007; Riaz et al., 2011). However, a recent study has shown 
that even the cytoplasm of interphase two-cell mouse embryos can reprogram somatic 
cells in SCNT, if the donor nucleus and recipient cytoplasm are synchronized (Kang et 
al., 2014). This suggests that the mitotic advantage is due to effective cell-cycle 
coordination, and not necessarily the presence of special reprogramming proteins only 
present in the recipient mitotic cytoplasm or a special mitotic chromatin configuration of 
the donor nucleus. It has long been known that the cytoplasm of an MII-arrested oocyte 
retains high activity of CDK that can efficiently lead to nuclear envelope breakdown, 
chromatin condensation and subsequent DNA replication of the donor nucleus from all 
cell cycle stages (Campbell et al., 1993). However, the cytoplasm of S-phase cells is less 
effective at synchronizing a G2-phase donor nucleus, unless the nuclear envelope is 
chemically permeabilized (Blow and Laskey, 1988). Thus, the nuclear envelope may act 
as a barrier for cell synchronization, which is eliminated during mitosis. Taken together, 
these seemingly conflicting reports seem to agree on the idea that resetting the somatic 
epigenome to pluripotency or totipotency can only be tolerated if supported by active cell 
division.     
 
Conclusions 
Throughout this Review, the link between cell fate decisions and the cell cycle has been 
emphasized in a developmental context using examples ranging from yeast to humans. 
The emerging general themes from this work indicate that cell fate decisions are context 
dependent with regard to their requirement for cell division. Both cell cycle-dependent 
and cell cycle-independent mechanisms have been highlighted. For example, terminal 
differentiation of muscle cells from immature precursors requires cell cycle exit whereas 
differentiation towards pancreatic and erythroid progenitors requires active division and 
phase-specific cell cycle activities. Similar variations have been reported in 
reprogramming to the pluripotent state and trans-differentiation across lineages. 
Irrespective of the requirement for cell division, the cell cycle machinery impacts these 
cellular decisions (see Table 1). For example, CDKI-regulated CDK inhibition is central to 
cell fate decisions made in a cell cycle-independent context, while elevated CDK activity 
is a requirement for most cell cycle-dependent cell fate decisions. Clearly then, it is critical 
to better understand the molecular basis underpinning cell fate decisions in each scenario 
in order to place the cell cycle in a broader developmental perspective.  
 We used PSCs as an example to highlight mechanisms that coordinate cell fate 
commitment with the cell cycle. In this scenario, cells transitioning through G1-phase are 
highly responsive to differentiation cues that target developmentally-regulated 
transcription factors and chromatin remodelers. In conjunction with developmental 
signals, the G1-CDK machinery collaborates with signal-regulated transcription factors 
such as SMADs to recruit co-repressors and co-activators to developmental genes. All 
together, these events result in chromosome remodeling, enhancer recruitment and the 
coordinated activation of a transcriptional program required for cell fate decisions. We 
refer to this G1-specific mechanism as lineage-priming. Interestingly, SMADs are known 
to act on loci primed by master transcription factors (Mullen et al., 2011), indicating the 
existence of a more elaborate mechanism for cell fate specification. Along with lineage-
priming, G1-phase represents a time when the pluripotency network is vulnerable to 
inactivation, also called dissolution, whereas in S-phase and G2-phase it is stabilized. 
Since pluripotent cells spend most time in the S-phase, this further suggests a connection 
between cell cycle stage and pluripotency wherein S-phase supports pluripotency while 
G1-phase represents a period of differentiation competency. Establishing a cell cycle 
where cells spend most time in S-phase and a brief time in G1-phase therefore minimizes 
the opportunity for pluripotent cells to switch state. Partitioning networks that sustain 
pluripotency or promote differentiation between different cell cycle phases seems a logical 
strategy to activate developmental genes and silence pluripotency genes in a coordinated 
manner.  Another mechanism implicated in marking chromatin for future decisions in 
pluripotent cells is mitotic bookmarking. These observations indicate that mitosis is 
required to lay the epigenomic foundations for a cell fate switch in G1-phase. In total, 
these observations imply that the entire cell cycle is part of a coordinated network that 
orchestrates cell fate decisions.  
 It is important to note that the cell cycle machinery components present in the 
cytoplasm must co-ordinate with the chromatin configuration of the genome in the nucleus 
in order to effectively make a cell fate decision. This is highly relevant to reprogramming 
and trans-differentiation as the field is moving towards generating cell types for clinical 
applications and disease modeling - especially when the efficiency and the fidelity of the 
current protocols represent the biggest challenge in the field. In order to achieve these 
prerequisite requirements, future research must not only concentrate on how to 
manipulate chromatin and gene expression but also how these changes fit within the cell 
cycle. Defining in greater detail the mechanistic aspects that connect cell fate switches to 
the cell cycle machinery will be instrumental in developing novel and effective methods 
to control cell types, as well as understanding whether this mechanism is a general 
feature of cell fate decisions or is restricted to specific cases.  
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Box 1: Mitotic bookmarking 
Mitotic bookmarking refers to the retention of epigenetic marks during mitosis that 
enables rapid gene activation upon entry into G1-phase. The 'bookmarks' include 
DNase-hypersensitive sites that mark accessible and active promoters and enhancers 
(Hsiung et al., 2015; Martínez-Balbás et al., 1995), acetylated H4K5 marks and residual 
bromodomain protein 4 (BRD4) marks (Dey et al., 2009; Zhao et al., 2011). The mixed 
lineage leukemia (MLL), an epigenetic modifier that maintains gene activity through 
catalyzing trimethylation of H3K4 at promoters (Blobel et al., 2009) and the poly(ADP-
ribose) polymerase-1 (PARP-1) are also retained in mitotic chromatin (Lodhi et al., 
2014). Interestingly, 'bookmarked' genes are rapidly reactivated upon entry into G1-
phase  (Fig. 3). In addition to chromatin modifiers, a select group of transcription factors 
such as FOXA1, GATA1, RUNX2, ESRRB and RBPJ also bind and 'bookmark' mitotic 
chromatin (Caravaca et al., 2013; Kadauke et al., 2012; Lake et al., 2014; Young et al., 
2007; Festuccia et al., 2016). Interestingly however, these factors maintain mitotic 
chromatin binding at only a subset of the specific sites bound during interphase 
(Caravaca et al., 2013; Kadauke et al., 2012). This reduced number of specific binding 
sites is not due to lower transcription/chromatin factor levels but instead, the majority of 
bookmarking events occur at non-specific sites with a highly dynamic exchange rate 
(Caravaca et al., 2013). Transcription factors with bookmarking activity such as FOXA1 
and GATA1 are thought to act as pioneer factors that reset the chromatin landscape 
and potentially, re-establish cell identity after mitosis (Zaret, 2014). Because OCT4, 
SOX2 and KLF4 (OSK) act as pioneer factors during reprogramming to pluripotency 
(Soufi et al., 2012) and because ASCL1 functions as a pioneer factor during trans-
differentiation of fibroblasts to neurons (Wapinski et al., 2013), it will be important to 
investigate the association of these reprogramming factors with mitotic chromatin and 
the role of this in cell cycle regulated cell fate decisions. 
 
 
 
 
 
 
 
Table. Cell cycle regulation of cell fate decisions and its regulation  
Cell cycle target Cell fate decision   Mechanism 
HDAC, SP1  pluripotent cell fate determination CYCLIN D  (G1-phase) 
SMAD2,3  pluripotent cell fate determination CDK4/6-CYCLIN D  (G1-phase) 
MLL2   pluripotent stem cell differentiation CDK2 (G1-phase) 
HO   budding yeast    CDK (G1-phase)  
unknown  pancreatic endocrine cell fate  G1-phase CDK regulated (?) 
GATA1   erythroid differentiation   KIP2p57 (S-phase)    
NOTCH   Drosophila sensory organ formation unknown (G2-phase) 
NGN2     neural progenitor differentiation  inhibition by CDK (G1-phase) 
unknown  cortical progenitor differentiation  unknown (G1-phase)  
Prospero  Drosophila neuroblast differentiation pro-differentiation, inhibits cell cycle 
machinery 
H2A    differentiation, reprogramming  window for reprogramming factors (mitosis) 
chromatin  reprogramming    OSK binding (mitosis) 
unknown  Dictyostylium pre-spore/stalk decision  nutritional conditions (G1-, S-, G2-phases) 
 
 
Figure legends 
 
Fig. 1. The cell cycle controls developmental decisions. The intersection between 
cell cycle control and cell fate determination mechanisms involves developmental 
signals and cyclin-dependent protein kinases (CDKs) targeting transcription factors that 
control developmental genes. CDKs also work in parallel to this pathway by modulating 
the epigenetic landscape and chromosome architecture around developmental genes. 
The activation of certain target genes determines important cell fate decisions and 
subsequent lineage commitment.  
 
Fig. 2. Mechanisms of lineage-priming and pluripotency dissolution in the G1-
phase of pluripotent stem cells (PSCs). As PSCs exit M-phase, G1-CDK activities 
are activated and in concert with developmental signals act through transcription factors 
which load onto developmental target genes. Developmental genes are 'bookmarked' 
epigenetically in mitosis for rapid activation in the upcoming G1-phase. In conjunction 
with this, epigenetic modifiers, such as MLL2, modify the local epigenetic landscape 
around developmental genes in G1-phase and Cyclin D recruits co-repressors and co-
activators. Chromosome loops are then formed, recruiting enhancers to the proximal 
promoter, thereby establishing the lineage-primed state. Before and after G1-phase, 
developmental genes are decommissioned due to the erasure of some epigenetic 
marks and chromosome loops. Outside of G1-phase, the pluripotency network is 
stabilized by S-phase and G2-phase regulators that block pluripotency dissolution. 
Dissolution of pluripotency and lineage-priming work in concert to orchestrate exit from 
pluripotency and initiate cell fate decisions in G1-phase. 
 
Fig. 3. Mitotic 'bookmarking' and entry into the lineage-primed state in G1-phase. 
(A) During mitosis the nuclear membrane is broken down and chromatin is highly 
condensed, as depicted by densely packed nucleosomes. Transcription then halts, 
coinciding with exclusion of the transcription machinery and most transcription factors 
from the nucleus. Pioneer factors are retained in mitotic chromatin both specifically and 
non-specifically. Chromatin modifiers such as MLL are retained by mitotic chromatin and 
'bookmark' promoters in preparation for activation in G1-phase. A subset of histone 
modifications, such as H3K9me3, are also retained in mitosis. H3 is specifically 
phosphorylated at S10 by the mitotic kinase AURORA B, resulting in the eviction of 
HP1. SUV39H is also phosphorylated during mitosis and dissociates from chromatin. 
(B) Upon mitotic exit, cells respond to differentiation signals, which are transduced to 
the nucleus through the action of Cyclin D, SMADs and other effectors. SMADs for 
example, bind with other transcription factors to sites specifically 'bookmarked' by 
pioneer factors during mitosis or primed by other transcription factors during early G1-
phase. Chromatin modifiers such as MLL or newly recruited transcription factors and 
CDK components re-establish histone modifications at enhancers and promoters and 
developmental genes are reset to the lineage-primed state. Also in G1-phase, H3S10 
phosphorylation is lost and HP1 and SUV39H bind to H3K9me3-enriched chromatin to 
re-establish heterochromatin, blocking access to transcription factors in these regions.  
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